Layout Ventures Research
Investment Thesis
Layout Ventures is a Los Angeles-based seed-stage venture firm that backs any innovative technology that makes healthcare cheaper, better, faster, or more accessible. The firm's stated mission is "unlocking the biggest missions impacting healthcare at the earliest stages." It is deliberately broad within healthcare: clinical products and behind-the-scenes (administrative, financial, operational) products both qualify, so long as the company sells into healthcare. The website describes the pitch to founders in three parts: focus (an early check in the first institutional round), impact (introductions to healthcare decision-makers who rarely engage with companies this early), and experience (the team has scaled multiple healthcare companies to exit and works with a bench of healthcare executive advisors).
Stage Focus
The firm targets the first institutional round of a company, which in practice means pre-seed and seed. The site says Layout invests in the first institutional round of any company that sells into healthcare. Several current portfolio companies are listed in stealth, which suggests Layout is often among the earliest outside investors.
Check Size
The website states the firm invests approximately $250K per company. No range is published, so the check size range here is an estimate centered on that figure.
Lead Tendency
Not stated. The firm describes itself as investing in the first institutional round, and the check size is small relative to a typical seed round, so it more likely participates or co-leads than leads large rounds. Recorded as unknown.
Fund and Recent Activity
Layout Ventures I, L.P. is a Delaware fund that filed an SEC Form D in June 2024. A later Form D amendment (June 2025) reported about $3.1M sold to 27 investors against a $10M target offering, so this is a small, emerging-manager fund and still deploying. The firm published a launch announcement on its site and through a LinkedIn post by the founder. The portfolio page lists five named companies and five stealth companies in the current fund, plus selected prior non-fund investments and advisor relationships.
Portfolio Highlights
Named fund investments:
- Ferry Health: AI to simplify and automate logistics and next-best-action in healthcare (founders Mehul Mehta, Andrew Buie)
- Stackpack: maximizing the return and compliance on every dollar spent (Sara Wyman)
- Branch Care: connects OBGYNs and REIs to deliver fertility care with shared oversight (Katie Agarwal, Eliza Wilson)
- Otter Health: real-time standard of care for prior authorization relief and managed performance (Keith Florance, Amol Navathe)
- Peppermint: AI-powered financial operations platform for clinical trials (David Freeman, Vijay Thurimella)
Stealth companies cover cell, gene and immune therapy delivery in existing clinics, dermatology and skin care, home health risk reports, AI documentation and oversight for trial operations, and utility grid infrastructure in space.
Selected prior (non-fund) investments: Apella (real-time operating room optimization), BotMD (patient access to healthcare monitoring), LaticaAI (analytics and intelligence for collaboration and research), and Trace (metric trees for business performance). Advisor-only relationships: SafeRide Health (NEMT technology) and Ostro (AI for HCP engagement, acquired by Veeva Systems).
Team
- Aaron Szekel, General Partner: founder and managing member of the general partner. Also a mentor at Mucker and a former venture partner at Fika Ventures, investing and advising across future of work, healthcare, and media. The website lists him as the only partner.
Decision Process
Solo GP. Aaron Szekel is the only listed investor and managing member of the general partner, so decisions rest with him, supported by an advisory bench of healthcare executives.
Founder Preferences
Founders building products that sell into healthcare, at the earliest stage, who value access to healthcare buyers and operators. The portfolio mixes AI-enabled administrative workflows (prior authorization, logistics, clinical trial finance) with care-delivery models (fertility care, dermatology). No stated preference on founder background, though several founding teams pair operators with clinicians.
Geographic Focus
No stated geographic restriction. The firm is in Los Angeles; the portfolio is U.S. healthcare-oriented. Warm introductions are not stated as required.